top-border

News

  • 19.02.2018

    Aurealis Pharma To Present at the 11th Annual European Life Sciences CEO Forum & Exhibition in Zurich, February 26-27th 2018

  • 06.02.2018

    Aurealis Pharma to Present at Swiss Nordic Bio 2018 in Zurich, February 8th 2018

  • 24.09.2017

    Aurealis Pharma to Present at Sachs Associates 17th Annual Biotech in Europe Forum Basel, September 26-27th 2017

  • 20.09.2017

    Aurealis Pharma to Present at BioPharm America 10th Annual International Partnering Conference in Boston, September 26-27th 2017

  • 25.08.2017

    Aurealis Pharma Announces 5.6MCHF Series A Financing to Advance Chronic Wound and Oncology Lead Products

  • Aurealis Pharma to Discuss AUP-16 Clinical Development at the 27th European Wound Managament Association Annual Meeting on May 3-5th 2017 in Amsterdam

  • Aurealis Pharma to Present at Swiss Biotech Day on May 4th 2017

  • 11.01.2017

    Aurealis Pharma to Attend 9th Annual Partnering Conference - Biotech Showcase, San Francisco, January 9-11th 2017

  • 12.10.2016

    Aurealis Pharma to Present at Sachs Associates 16th Annual Biotech in Europe Forum Basel, September 27-28th 2016

  • 10.05.2016

    Aurealis Pharma Expands Its Board of Directors with Mr. Silvio Inderbitzin and Mr. Roger Meier

  • 08.04.2016

    Aurealis Pharma to Attend Swiss Biotech Day on April 12th 2016

  • 06.04.2016

    Aurealis Pharma to Move Swiss Offices to Technology Park Basel

  • 24.03.2016

    Aurealis Pharma to Showcase at BioTrinity 2016 - Europe's Leading Investment and Biopartnering Conference, London, April 25-27th 2016

  • 22.01.2016

    Aurealis Pharma Extends Microbiology, Genetic Engineering and Manufacturing Expertise by Recruitment of Industry Expert Dr. Igor Mierau

  • 07.01.2016

    Aurealis Pharma Completes 3.3MCHF Seed C Financing to Advance Its Multitherapy Biologics

  • 04.09.2015

    Aurealis Pharma Expands its Management Team and Announces Opening of New Office In Basel Switzerland

  • 13.05.2015

    Aurealis Pharma to Attend BioEquity Europe 2015 Conference, Vienna on May 19-20th 2015

  • 04.05.2015

    Aurealis Pharma to Present at Asia Biotech Invest 2015 Conference on May 21st 2015

  • 16.04.2015

    Aurealis Pharma to Present at BioTrinity 2015 - European Biopartnering and Investment Conference on May 12th 2015

  • 13.04.2015

    Aurealis Pharma Completes Second Round of Seed Financing to Advance Its Immune Microenvironment Modulation Technology


Back to previous page

bottom-border

Aurealis Pharma

Embracing science. Enhancing lives.

Site by Mainostoimisto Ad Kiivi